Middle Molecular Uremic Toxin and Blood Purification Therapy

Hideki Kawanishi1

  • 1Tsuchiya General Hospital, 3-30 Nakajima-cho Naka-ku, Hiroshima 730-8655, Japan.

PubMed

Insights

Blood purification therapy removes uremic toxins, targeting middle molecules (MMs). New research highlights the antioxidant role of alpha1-microglobulin (aMG), a large-middle molecule, potentially advancing treatment strategies.

Area of Science:

  • Nephrology
  • Biochemistry
  • Medical Technology

Background:

  • Blood purification therapy aims to eliminate uremic toxins.
  • Middle molecules (MMs) are key targets, classified by molecular weight (0.5-58 kDa).
  • New classifications include small-middle (0.5-15 kDa), medium-middle (15-25 kDa), and large-middle (25-58 kDa) MMs.

Purpose of the Study:

  • To discuss the role of middle molecules in blood purification.
  • To introduce new classifications for middle molecules.
  • To explore the physiological function of alpha1-microglobulin (aMG) beyond toxin removal.

Main Methods:

  • Literature review on middle molecule classification and removal.
  • Discussion of emerging theories on aMG function.
  • Analysis of current blood purification strategies focusing on large-middle molecules.

Main Results:

  • Proposed new classifications for middle molecules based on size.
  • Highlighted the antioxidant properties of alpha1-microglobulin (aMG).
  • Shift in focus from solely removal to understanding the physiological roles of MMs.

Conclusions:

  • Understanding the antioxidant effect of aMG is crucial.
  • Further clinical validation of aMG's physiological function is needed.
  • This research may drive advancements in blood purification therapies.

Related Concept Videos

Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
511
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
310
Filtration and Urine Formation01:32

Filtration and Urine Formation

The function of the kidneys is to filter, reabsorb, secrete, and excrete. Every day the kidneys filter nearly 180 liters of blood, initially removing water and solutes but ultimately returning nearly all filtrates into circulation with the help of osmoregulatory hormones. This process removes wastes and toxins but is also crucial to maintain water and electrolyte levels. Most of these functions are performed by the tiny but numerous nephrons contained within the kidneys.
50.1K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
183